Cresset Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,665
Closed -$753K 870
2022
Q3
$753K Sell
10,665
-7
-0.1% -$599 0.01% 414
2022
Q2
$757K Buy
10,672
+2,004
+23% +$129K 0.01% 438
2022
Q1
$693K Buy
8,668
+1,994
+30% +$148K 0.01% 503
2021
Q4
$610K Buy
6,674
+1,046
+19% +$112K 0.01% 631
2021
Q3
$723K Hold
5,628
0.01% 492
2021
Q2
$858K Buy
+5,628
New +$741K 0.01% 399

Other funds holding STAA

Cresset Asset Management's STAA Position: Q4 2022 in Review

Cresset Asset Management sold out of STAAR Surgical (STAA) in Q4 2022, closing a stake of 10,665 shares — an estimated $753K sold.

Cresset Asset Management first reported a position in STAA in Q2 2021 and held it in 6 quarters. The position peaked at $858K in Q2 2021. 275 funds tracked by Wall St. Rank hold STAA as of Q4 2022.

  • Cresset Asset Management reported no remaining STAAR Surgical position as of Q4 2022 after selling out during the quarter.
  • Cresset Asset Management sold 10,665 STAAR Surgical shares in Q4 2022, an estimated $753K.
  • Cresset Asset Management first reported a position in STAAR Surgical in Q2 2021 and held it in 6 quarters.
  • Cresset Asset Management's STAAR Surgical position peaked at $858K in Q2 2021.
  • 275 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2022.

Based on Cresset Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.